Intelligent Bio Solutions Inc. (INBS)
USD 1.27
(-6.62%)
USD 1.27
(-6.62%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -10.15 Million USD | 4.47% |
| 2023 | -10.63 Million USD | -28.0% |
| 2022 | -8.3 Million USD | -18.03% |
| 2021 | -7.03 Million USD | -122.43% |
| 2020 | -3.16 Million USD | 56.88% |
| 2019 | -7.33 Million USD | -46.14% |
| 2018 | -5.02 Million USD | -1376.56% |
| 2017 | -340 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -10.15 Million USD | 4.47% |
| 2024 Q1 | -2.42 Million USD | 8.79% |
| 2024 Q2 | -1.96 Million USD | 18.78% |
| 2024 Q3 | -2.97 Million USD | -51.18% |
| 2024 Q4 | -2.78 Million USD | 6.64% |
| 2023 Q4 | -2.65 Million USD | 58.09% |
| 2023 FY | -10.63 Million USD | -28.0% |
| 2023 Q3 | -6.34 Million USD | -1408.3% |
| 2023 Q2 | -420.6 Thousand USD | 65.19% |
| 2023 Q1 | -1.2 Million USD | 41.86% |
| 2022 Q2 | -3.45 Million USD | -141.51% |
| 2022 Q4 | -2.07 Million USD | -55.64% |
| 2022 Q3 | -1.33 Million USD | 61.41% |
| 2022 Q1 | -1.43 Million USD | -67.95% |
| 2022 FY | -8.3 Million USD | 24.65% |
| 2021 Q4 | -852.99 Thousand USD | 72.73% |
| 2021 Q1 | -1.07 Million USD | -134.68% |
| 2021 Q2 | -1.98 Million USD | -84.98% |
| 2021 FY | -11.02 Million USD | -196.8% |
| 2021 Q3 | -3.12 Million USD | -57.65% |
| 2020 Q1 | -757.85 Thousand USD | 76.18% |
| 2020 FY | -3.71 Million USD | 49.38% |
| 2020 Q3 | -112.59 Thousand USD | 93.87% |
| 2020 Q4 | -457.01 Thousand USD | -305.9% |
| 2020 Q2 | -1.83 Million USD | -142.31% |
| 2019 Q3 | -1.58 Million USD | 0.0% |
| 2019 FY | -7.33 Million USD | -46.14% |
| 2019 Q4 | -3.18 Million USD | -100.75% |
| 2019 Q1 | -1.65 Million USD | 11.19% |
| 2018 Q3 | -839.61 Thousand USD | 0.0% |
| 2018 Q4 | -1.86 Million USD | -122.6% |
| 2018 FY | -5.02 Million USD | -1510.79% |
| 2017 FY | -311.67 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | 95.631% |
| Prenetics Global Limited | -62.72 Million USD | 83.807% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -556.121% |
| CareDx, Inc | -190.28 Million USD | 94.662% |
| Exact Sciences Corporation | -204.14 Million USD | 95.025% |
| Exagen Inc. | -23.68 Million USD | 57.125% |
| Inotiv, Inc. | -105.14 Million USD | 90.34% |
| Guardant Health, Inc. | -479.44 Million USD | 97.882% |
| Biodesix, Inc. | -52.14 Million USD | 80.522% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -286.329% |
| Precipio, Inc. | -5.85 Million USD | -73.531% |
| iSpecimen Inc. | -11.09 Million USD | 8.493% |
| Natera, Inc. | -434.8 Million USD | 97.664% |
| Aspira Women's Health Inc. | -16.69 Million USD | 39.145% |
| Standard BioTools Inc. | -74.65 Million USD | 86.395% |
| 23andMe Holding Co. | -666.7 Million USD | 98.477% |
| Castle Biosciences, Inc. | -57.46 Million USD | 82.326% |
| Personalis, Inc. | -108.29 Million USD | 90.621% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | 88.521% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -2.108% |
| OpGen, Inc. | -32.66 Million USD | 68.91% |
| T2 Biosystems, Inc. | -50.07 Million USD | 79.718% |
| Myriad Genetics, Inc. | -112 Million USD | 90.931% |
| ICON Public Limited Company | 612.33 Million USD | 101.659% |
| NeoGenomics, Inc. | -87.96 Million USD | 88.454% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -556.121% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 101.202% |
| RadNet, Inc. | 3.04 Million USD | 433.665% |
| MDxHealth SA | -43.1 Million USD | 76.434% |
| Psychemedics Corporation | -4.15 Million USD | -144.506% |
| Illumina, Inc. | -1.16 Billion USD | 99.125% |
| Check-Cap Ltd. | -17.56 Million USD | 42.186% |
| Twist Bioscience Corporation | -208.72 Million USD | 95.134% |
| DarioHealth Corp. | -59.42 Million USD | 82.909% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 93.948% |
| Sera Prognostics, Inc. | -36.24 Million USD | 71.975% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -0.959% |
| OPKO Health, Inc. | -188.86 Million USD | 94.622% |
| Medpace Holdings, Inc. | 282.81 Million USD | 103.591% |
| Neogen Corporation | -9.42 Million USD | -7.81% |
| Prenetics Global Limited | -62.72 Million USD | 83.807% |
| Mainz Biomed B.V. | -26.29 Million USD | 61.375% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -27.967% |
| Trinity Biotech plc | -24.01 Million USD | 57.712% |
| Neuronetics, Inc. | -30.18 Million USD | 66.356% |
| Sotera Health Company | 51.37 Million USD | 119.769% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -27.967% |